GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » EV-to-FCF

Lobe Sciences (XCNQ:LOBE) EV-to-FCF : -29.02 (As of May. 15, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Lobe Sciences's Enterprise Value is C$3.66 Mil. Lobe Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.13 Mil. Therefore, Lobe Sciences's EV-to-FCF for today is -29.02.

The historical rank and industry rank for Lobe Sciences's EV-to-FCF or its related term are showing as below:

XCNQ:LOBE' s EV-to-FCF Range Over the Past 10 Years
Min: -29.02   Med: -0.87   Max: 1.81
Current: -29.02

During the past 13 years, the highest EV-to-FCF of Lobe Sciences was 1.81. The lowest was -29.02. And the median was -0.87.

XCNQ:LOBE's EV-to-FCF is ranked worse than
100% of 378 companies
in the Biotechnology industry
Industry Median: 7.545 vs XCNQ:LOBE: -29.02

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-15), Lobe Sciences's stock price is C$0.02. Lobe Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.020. Therefore, Lobe Sciences's PE Ratio for today is At Loss.


Lobe Sciences EV-to-FCF Historical Data

The historical data trend for Lobe Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences EV-to-FCF Chart

Lobe Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Aug19 Aug20 Aug21 Aug22 Aug23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.04 -8.30 -1.42 -1.01 -1.26

Lobe Sciences Quarterly Data
Dec18 Mar19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 Aug23 Nov23 Feb24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.33 -0.81 -1.26 -3.41 -15.44

Competitive Comparison of Lobe Sciences's EV-to-FCF

For the Biotechnology subindustry, Lobe Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lobe Sciences's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lobe Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Lobe Sciences's EV-to-FCF falls into.



Lobe Sciences EV-to-FCF Calculation

Lobe Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3.657/-0.126
=-29.02

Lobe Sciences's current Enterprise Value is C$3.66 Mil.
Lobe Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lobe Sciences  (XCNQ:LOBE) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Lobe Sciences's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.02/-0.020
=At Loss

Lobe Sciences's share price for today is C$0.02.
Lobe Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.020.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Lobe Sciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Lobe Sciences (XCNQ:LOBE) Business Description

Traded in Other Exchanges
Address
1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5
Lobe Sciences Ltd is a technology and services company that provides real estate, financial, management, IP, and branding support for the development of transformational medicine. It is working to develop effective psilocybin-based therapeutics for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of medications.

Lobe Sciences (XCNQ:LOBE) Headlines

No Headlines